A Dilute-and-Shoot LC–MS/MS Method for Screening of 43 Cardiovascular Drugs in Human Urine

IF 0.4 Q4 SPECTROSCOPY Mass Spectrometry Letters Pub Date : 2021-01-01 DOI:10.5478/MSL.2021.12.1.1
T. Pham, Gunhee Lee, X. Mai, Thi-Anh-Tuyet Le, Thi-Ngoc-Van Nguyen, Jongki Hong, K. Kim
{"title":"A Dilute-and-Shoot LC–MS/MS Method for Screening of 43 Cardiovascular Drugs in Human Urine","authors":"T. Pham, Gunhee Lee, X. Mai, Thi-Anh-Tuyet Le, Thi-Ngoc-Van Nguyen, Jongki Hong, K. Kim","doi":"10.5478/MSL.2021.12.1.1","DOIUrl":null,"url":null,"abstract":"A simple, specific, and economical LC–MS/MS method was investigated for the screening of 43 prescribed antihypertensive and related drugs in human urine. The urine samples were simply prepared by diluting and mixing with internal standard before directly introduced to the LC-MS/MS system, which is fast, straightforward, and cost-effective. Fractional factorial, Box-Behnken, and I-optimal design were applied to screen and optimize the mass spectrometric and chromatographic factors. The analysis was carried out on a triple quadrupole mass spectrometer system utilizing multiple reaction monitoring with positive and negative electrospray ionization method. Chromatographic separation was performed on a Thermo Scientific Accucore RP-MS column (50 × 3.0 mm ID., 2.6 μm) using two separate gradient elution programs established with the same mobile phases. Chromatographic separation was performed within 12 min. The optimal method was validated based on FDA guideline. The results indicated that the assay was specific, reproducible, and sensitive with the limit of detection from 0.1 to 50.0 μg/L. The method was linear for all analytes with coefficient of determination ranging from 0.9870 to 0.9981. The intra-assay precision was from 1.44 to 19.87% and the inter-assay precision was between 2.69 and 18.54% with the recovery rate ranges from 84.54 to 119.78% for all drugs measured. All analytes in urine samples were stable for 24 h at 25oC, and for 2 weeks at -60oC. The developed method improves on currently existing methods by including larger number of cardiovascular medications and better sensitivity of 12 analytes.","PeriodicalId":18238,"journal":{"name":"Mass Spectrometry Letters","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mass Spectrometry Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5478/MSL.2021.12.1.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SPECTROSCOPY","Score":null,"Total":0}
引用次数: 1

Abstract

A simple, specific, and economical LC–MS/MS method was investigated for the screening of 43 prescribed antihypertensive and related drugs in human urine. The urine samples were simply prepared by diluting and mixing with internal standard before directly introduced to the LC-MS/MS system, which is fast, straightforward, and cost-effective. Fractional factorial, Box-Behnken, and I-optimal design were applied to screen and optimize the mass spectrometric and chromatographic factors. The analysis was carried out on a triple quadrupole mass spectrometer system utilizing multiple reaction monitoring with positive and negative electrospray ionization method. Chromatographic separation was performed on a Thermo Scientific Accucore RP-MS column (50 × 3.0 mm ID., 2.6 μm) using two separate gradient elution programs established with the same mobile phases. Chromatographic separation was performed within 12 min. The optimal method was validated based on FDA guideline. The results indicated that the assay was specific, reproducible, and sensitive with the limit of detection from 0.1 to 50.0 μg/L. The method was linear for all analytes with coefficient of determination ranging from 0.9870 to 0.9981. The intra-assay precision was from 1.44 to 19.87% and the inter-assay precision was between 2.69 and 18.54% with the recovery rate ranges from 84.54 to 119.78% for all drugs measured. All analytes in urine samples were stable for 24 h at 25oC, and for 2 weeks at -60oC. The developed method improves on currently existing methods by including larger number of cardiovascular medications and better sensitivity of 12 analytes.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
稀释-射击LC-MS /MS法筛选人尿中43种心血管药物
研究了一种简便、特异、经济的LC-MS /MS方法对43种处方降压药及相关药物进行筛选。尿液样品只需与内标品稀释混合,然后直接导入LC-MS/MS系统即可制备,快速、简单、经济。采用分数因子、Box-Behnken和I-optimal设计对质谱和色谱因素进行筛选和优化。在三重四极质谱系统上进行了分析,采用正负电喷雾电离法进行多重反应监测。色谱分离采用Thermo Scientific Accucore RP-MS柱(50 × 3.0 mm ID)。采用两种不同的梯度洗脱程序,以相同的流动相建立。在12 min内进行色谱分离。根据FDA指南对最佳方法进行了验证。结果表明,该方法专属性强,重复性好,灵敏度高,检出限为0.1 ~ 50.0 μg/L。该方法对所有分析物均呈线性,测定系数在0.9870 ~ 0.9981范围内。测定药物的内精密度为1.44 ~ 19.87%,内精密度为2.69 ~ 18.54%,加样回收率为84.54 ~ 119.78%。尿液样品中的所有分析物在25℃下稳定24小时,在-60℃下稳定2周。所开发的方法在现有方法的基础上进行了改进,包括更多的心血管药物和12种分析物的更高灵敏度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.90
自引率
20.00%
发文量
0
审稿时长
6 weeks
期刊最新文献
Estimation of Phosphorus Concentration in Silicon Thin Film on Glass Using ToF-SIMS Statistical Characterization of the Multi-Charged Fragment Ions in the CID and HCD Spectrum Screening of Nitrosamine Impurities in Sartan Pharmaceuticals by GC-MS/MS Effect of Ginsenoside Rc on the Pharmacokinetics of Mycophenolic Acid, a UGT1A9 Substrate, and its Glucuronide Metabolite in Rats A Study on the Reduction of Inorganic Arsenic in Hijiki and Rice Using the Various Pretreatments and Inductively Coupled Plasma Mass Spectrometry
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1